Whittier Trust’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,292
| Closed | -$22K | – | 1516 |
|
|
2020
Q3 | $22K | Buy |
+2,292
| New | +$21.8K | ﹤0.01% | 990 |
|
|
2020
Q2 | – | Sell |
-2,292
| Closed | -$14K | – | 1557 |
|
|
2020
Q1 | $14K | Hold |
2,292
| – | – | ﹤0.01% | 1060 |
|
|
2019
Q4 | $28K | Hold |
2,292
| – | – | ﹤0.01% | 962 |
|
|
2019
Q3 | $26K | Hold |
2,292
| – | – | ﹤0.01% | 978 |
|
|
2019
Q2 | $23K | Hold |
2,292
| – | – | ﹤0.01% | 936 |
|
|
2019
Q1 | $30K | Hold |
2,292
| – | – | ﹤0.01% | 879 |
|
|
2018
Q4 | $35K | Hold |
2,292
| – | – | ﹤0.01% | 854 |
|
|
2018
Q3 | $46K | Hold |
2,292
| – | – | ﹤0.01% | 793 |
|
|
2018
Q2 | $45K | Hold |
2,292
| – | – | ﹤0.01% | 784 |
|
|
2018
Q1 | $46K | Hold |
2,292
| – | – | ﹤0.01% | 795 |
|
|
2017
Q4 | $30K | Hold |
2,292
| – | – | ﹤0.01% | 861 |
|
|
2017
Q3 | $42K | Hold |
2,292
| – | – | ﹤0.01% | 775 |
|
|
2017
Q2 | $42K | Hold |
2,292
| – | – | ﹤0.01% | 749 |
|
|
2017
Q1 | $52K | Hold |
2,292
| – | – | ﹤0.01% | 705 |
|
|
2016
Q4 | $80K | Hold |
2,292
| – | – | ﹤0.01% | 628 |
|
|
2016
Q3 | $56K | Hold |
2,292
| – | – | ﹤0.01% | 675 |
|
|
2016
Q2 | $55K | Hold |
2,292
| – | – | ﹤0.01% | 701 |
|
|
2016
Q1 | $54K | Hold |
2,292
| – | – | ﹤0.01% | 704 |
|
|
2015
Q4 | $69K | Buy |
+2,292
| New | +$74K | ﹤0.01% | 665 |
|
Whittier Trust's AMAG Position: Q4 2020 in Review
Whittier Trust sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 2,292 shares — an estimated $22K sold.
Whittier Trust first reported a position in AMAG in Q4 2015 and held it in 19 quarters. The position peaked at $80K in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Whittier Trust reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Whittier Trust sold 2,292 AMAG Pharmaceuticals shares in Q4 2020, an estimated $22K.
- Whittier Trust first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 19 quarters.
- Whittier Trust's AMAG Pharmaceuticals position peaked at $80K in Q4 2016.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Whittier Trust's 13F filing for Q4 2020, filed 29 Jan 2021.